The Claim
Apigenin reduces glycerol release from mouse 3T3-L1 adipocytes, indicating a net suppression of lipid mobilization despite unchanged lipolytic gene expression, suggesting complex regulation of fat breakdown.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin decreases the release of glycerol from mouse fat cells, showing that fat breakdown is reduced even though the genes involved in fat breakdown remain unchanged.
See the scientific wording
Apigenin reduces glycerol release from mouse 3T3-L1 adipocytes, indicating a net suppression of lipid mobilization despite unchanged lipolytic gene expression, suggesting complex regulation of fat breakdown.
Apigenin turns on a cellular energy sensor called AMPK, which blocks the release of fat from fat cells without changing the genes that control fat breakdown. This means fat stays stored even though the cell's instructions to break it down remain the same.
What the research says
1 studyStudy: Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells.
Even though apigenin doesn’t change the genes that tell fat cells to break down fat, it still causes less glycerol to be released — meaning it’s slowing fat breakdown in a way that genes alone can’t explain.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.